New TECH Talk: Nucleus® Sound Processor for pediatric patients

Share

Dr. Jace Wolfe, audiologist and Director of Audiology and Research at the Hearts for Hearing Foundation in Oklahoma City, discusses why the Cochlear™ Nucleus® Sound Processor is his choice for pediatric patients.

Wolfe cites durability and reliability as top considerations for external sound processors, especially for kids during play. Many children can’t deliver robust feedback right away, so the sound processor needs to work as promised. In addition, he attributes Nucleus Sound Processors as the smallest sound processor on the market, which is key for infants and wearability.1

Further, Wolfe discusses technological advancements that can aid pediatric progress and care, such as the Nucleus Smart App.* This app allows parents/caregivers to see how long the child spends in various listening environments and can help set virtual goals as well.

Lastly, the Nucleus 7 Sound Processor has True Wireless™ technology that allows more access via the remote microphone system. According to a recent Vanderbilt Study, this can afford kids to hear about 5000 more words per day, which propels them toward the goal of hearing 46 million words by four years of age.2

Watch now!

To learn more about early implantation and our new lowered pediatric indication visit our TECH Talks page or website.

References:

  1. Cochlear Limited. D1190805. CP1000 Processor Size Comparison. 2017, Mar; Data on file
  2. Benítez-Barrera CR, Angley GP, Tharpe AM. Remote Microphone System Use at Home: Impact on Caregiver Talk. J Speech Lang Hear Res. 2018;61(2):399‐409. doi:10.1044/2017_JSLHR-H-17-0168

In the US, the cochlear implant system is intended for use in children 9 to 24 months of age who have bilateral profound sensorineural deafness and demonstrate limited benefit from appropriate binaural hearing aids. Children two years of age or older may demonstrate severe to profound hearing loss bilaterally. In Canada, the cochlear implant system is intended for use in children 12 to 24 months of age who have bilateral profound sensorineural deafness and demonstrate limited benefit from appropriate binaural hearing aids. Children two years of age or older may demonstrate severe to profound hearing loss bilaterally.

*The Cochlear Nucleus 7 Sound Processor is compatible with iPhone®, iPad® and iPod® touch. Apple, the Apple logo, FaceTime, Made for iPad logo, Made for iPhone logo, Made for iPod logo, iPhone®, iPad® Pro, iPad® Air, iPad® mini, iPad® and iPod® touch are trademarks of Apple Inc., registered in the U.S. and other countries. The Cochlear Nucleus Smart App is available on App Store and Google Play. For complete smartphone compatibility information, please visit www.cochlear.com/compatibility.

App Store is a service mark of Apple Inc., registered in the U.S. and other countries.

Android™ and Google Play are registered trademarks of Google Inc.

Related Posts